Cargando…
Interleukin 1 level, cognitive performance, and severity of depressive symptoms in patients treated with systemic anticancer therapy: a prospective study
AIM: To assess the relationship between cognitive functions, severity of depressive symptoms, and expression of interleukin 1 (IL)-1 in patients treated with systemic anticancer therapy. METHODS: This prospective study, conducted in 2017-2018, involved 55 patients (56% men) subjected to systemic ant...
Autores principales: | Jasionowska, Justyna, Talarowska, Monika, Kalinka, Ewa, Skiba, Aleksandra, Szemraj, Janusz, Mikołajczyk, Iwona, Gałecki, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Medical Schools
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509622/ https://www.ncbi.nlm.nih.gov/pubmed/31044590 http://dx.doi.org/10.3325/cmj.2019.60.166 |
Ejemplares similares
-
The role of interleukin genes in the course of depression
por: Talarowska, Monika, et al.
Publicado: (2016) -
Is NRXN1 Gene Expression an Important Marker of Treatment of Depressive Disorders? A Pilot Study
por: Skiba, Aleksandra, et al.
Publicado: (2021) -
Decision support for assessment of left ventricular diastolic function
por: Tamás, Éva, et al.
Publicado: (2018) -
Identification of Polymorphisms in the
HERC2-OCA2 Gene Locus and their Association with
Feather Color in Quail
por: Zhang, Xiaohui, et al.
Publicado: (2023) -
Serum KIBRA mRNA and Protein Expression and Cognitive Functions in Depression
por: Talarowska, Monika, et al.
Publicado: (2016)